Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder
Open Access
- 1 August 2006
- journal article
- medical genetics-in-practice
- Published by BMJ in Journal of Medical Genetics
- Vol. 43 (8) , 665-670
- https://doi.org/10.1136/jmg.2005.039172
Abstract
Objective: To increase the awareness among at risk relatives of the availability of genetic testing for a familial disorder while respecting their autonomy and privacy. Methods: This was a comparison of preintervention and postintervention cohorts of families carried out in a state wide clinical service providing genetic counselling and testing for people at risk of familial adult onset cancer. Unaffected relatives who were not clients of the service in 74 kindreds with familial mutations causing familial breast and ovarian cancer, hereditary non-polyposis colorectal cancer, or Cowden syndrome were included in the study. In the baseline cohort (41 kindreds), family members who were clients of the clinical service and had been shown to be carriers of mutations were asked to advise relatives that genetic testing was available. In the intervention cohort (33 kindreds), the clinical service obtained consent to advise at risk relatives by letter that genetic testing was available. The main outcome measures were: (a) proportion of unaffected first and second degree relatives of the proband in each family whose genetic status was clarified within 2 years of the mutation being identified in the family, and (b) concerns regarding privacy and autonomy voiced by relatives receiving these letters. Results: In the baseline cohort, the average proportion of relatives in each family whose genetic status was clarified was 23%. In the intervention cohort, the average proportion of relatives in each family whose genetic status was clarified was 40% (p = 0.001). None of the relatives in the intervention cohort complained of a breach of privacy or autonomy. Conclusion: Clinical services can take an effective and proactive approach to notifying relatives who are not their clients of the availability of genetic testing without compromising principles of privacy and autonomy.Keywords
This publication has 24 references indexed in Scilit:
- Medical geneticists' duty to warn at‐risk relatives for genetic diseaseAmerican Journal of Medical Genetics Part A, 2003
- Communication of BRCA1 and BRCA2 results to at‐risk relatives: A cancer risk assessment program's experienceAmerican Journal Of Medical Genetics Part C-Seminars In Medical Genetics, 2003
- Comparison of genetic services with and without genetic registers: access and attitudes to genetic counselling services among relatives of genetic clinic patientsJournal of Medical Genetics, 2002
- Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patientsAmerican Journal of Medical Genetics Part A, 2002
- All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test resultsAmerican Journal of Medical Genetics, 2001
- Parental communication of BRCA1/2 genetic test results to childrenPatient Education and Counseling, 2001
- Disclosure of familial genetic information: perceptions of the duty to informThe American Journal of Medicine, 2000
- Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction.2000
- Patients' rights or family responsibilities? Two approaches to genetic testingMedical Law Review, 1998
- Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.1994